ClinicalTrials.Veeva

Menu

The Rates of Overtreatment and Deintensification in Patients With Diabetes Mellitus

G

Gulhane School of Medicine

Status

Completed

Conditions

Diabetes Mellitus

Study type

Observational

Funder types

Other

Identifiers

NCT03503045
GSM-012018

Details and patient eligibility

About

This study evaluates the overtreatment and deintensification rates of antidiabetic and antihypertensive medications in patients with diabetes mellitus in Turkey.

Full description

Diabetes mellitus is one of the most common chronic diseases which lead to serious public health problems and a significant economic burden worldwide. The prevalence of diabetes in elderly patients is very high and is predicted to increase dramatically.

Prior studies have generally been concerned with the inadequate treatment of diabetes however, over the last few years the overtreatment of diabetes has also come to the fore. Unfortunately, there are very few data worldwide and no data in Turkey about the overtreatment of patients with type 2 diabetes.

This study aimed to assess the rates and predictors of overtreatment and undertreatment of glycemia and blood pressure in older adults with T2DM. Treatment deintensification or intensification by the physicians were also investigated.

Enrollment

1,276 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Diabetes Mellitus type I or II
  • Age 65 years or older
  • To be under follow-up in the same center for at least one year.

Exclusion criteria

  • Younger than 65 years old
  • having decompensated liver disease
  • psychiatric disorders interfering cognition or compliance
  • having bariatric surgery or on renal replacement therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems